跳至主要内容
临床试验/NCT01107613
NCT01107613已完成不适用

Opinion Leaders to Improve Care After COPD or Asthma Emergency Department (ED) Visits.

University of Alberta2 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2011年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
128
试验地点
2
主要终点
Follow-up with primary care provider

研究概览

简要总结

This study will enroll patients who present to Emergency Departments (EDs) and have an acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD) or asthma at discharged in one Edmonton ED. Patients will all be provided with evidence-based discharge (prednisone and an antibiotic for COPD and prednisone and inhaled corticosteroids for asthma) and will be randomized to receive enhanced education to the primary care provider or standard care. The investigators' goal is to determine if an opinion leaders' advice will improve chronic care in these patients.

详细描述

Chronic Obstructive Pulmonary Disease (COPD) is the 4th leading cause of morbidity and mortality worldwide. COPD is now seen as a disease that is both preventable and treatable. In order to better facilitate treatment for these patients, a number of consensus guidelines have been developed to help physicians in the diagnosis and chronic management of these patients. However, a number of studies have shown that implementation and adherence to the guidelines by physicians, both at the primary care and specialist level, remains poor. Similar argument can be made for asthma: its a common disease, its readily treatable, and guideline compliance is low.

Patients who experience an Acute Exacerbation of COPD (AECOPD) or asthma have an increased risk of serious adverse events, and therefore, must have their management optimized to improve outcomes. These patients most often are evaluated and treated in their local emergency departments (EDs) for the acute episode; however, follow up care is often left to their primary care physician (PCP). The national rate of patient compliance for follow up with their PCP within the first month following an AECOPD is unknown, however, locally, it is only 30%. Similar local statistics are available for asthma From this, it could be inferred that there is a poor rate for any adjustment in chronic management after an AECOPD or acute asthma presentation and therefore an increased risk of future exacerbations.

It is our belief that informing the PCP that their patient experienced an acute COPD or asthma ED presentation, with a form that provides details of the acute management along with an update of the current guideline recommendations, will improve follow up, compliance with current guidelines and the quality of life for patients with COPD or asthma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Appropriately signed and dated informed consent has been obtained;
  • •ED patients presenting with an acute exacerbation of COPD requiring treatment in the ED;
  • •Previous physician-diagnosis of COPD (e.g., emphysema, chronic bronchitis or COPD) either previously or within the ED;
  • •Age > 40 years of age;
  • •Current or former smokers of more than 10 pack years (number of packs of cigarettes {or pipe and/or cigars) smoked per day X the number of years of smoking);
  • •FEV1/FVC ratio < 0.7 for age, sex and height (either known or determined within the ED);
  • •Patients can read and comprehend English language.

排除标准

  • •Patients presenting for prescription renewal;
  • •Patients who require hospitalization;
  • •Patients who do not have a primary care physician or patients for whom a family physician cannot be found;
  • •Patients who have already been enrolled in the study;
  • •Patients with a ED physician-diagnosis of primary asthma, pneumonia, HIV/AIDS, immuno-compromise, or life expectance of < 90 days;
  • •Patients who, in the opinion of the investigator, should be excluded.

研究组 & 干预措施

Intervention Arm

Experimental

Opinion leader educational letter

干预措施: Opinion leader educational letter (Behavioral)

Control/Standard Care

No Intervention

Regular care

结局指标

主要结局

Follow-up with primary care provider

时间窗: 90 days

The follow-up of the patient by their primary care provider for review of the acute and chronic management of their COPD or asthma and addressing any issues on the Lung Attack Alert, within the first 90 days after discharge from the ED.

次要结局

  • Referrals(90 days)
  • Relapse(90 days)
  • Adjusted management(90 days)
  • Length of ED Stay(Up to 24 hours)
  • Quality of life(90 days)
  • Follow-up with primary care provider(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验